Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-processed foods, lifestyle management, and cardiovascular diseases: A clinical consensus statement of the European Society of Cardiology Council for Cardiology Practice and the European Association of Preventive Cardiology of the European Society of Cardiology.

European heart journal·2026
Same author

The Role of β-Blockers in the Evolving Treatment Landscape of Resistant Hypertension.

Drugs·2026
Same author

Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data.

Thrombosis research·2025
Same author

Prime Time for (im) Precision Medicine: From Randomized Clinical Trials to Real-World Evidence.

European journal of preventive cardiology·2025
Same author

European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice.

Nature reviews. Cardiology·2025
Same author

Feasibility and safety of renal nerve stimulation using the direct wire pacing (DWP®) technique during renal denervation procedure: A first-in-human study.

Cardiovascular revascularization medicine : including molecular interventions·2025

Related Experiment Video

Updated: Jul 5, 2026

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Nano-vectors for efficient liver specific gene transfer.

Atul Pathak1, Suresh P Vyas, Kailash C Gupta

  • 1Nucleic Acids Research Laboratory, Institute of Genomics and Integrative Biology, Delhi University Campus, Delhi, India.

International Journal of Nanomedicine
|May 21, 2008
PubMed
Summary
This summary is machine-generated.

Nanotechnology enables targeted DNA delivery to liver cells for treating genetic and acquired diseases. Various nano-vectors show promise for developing new liver disorder pharmaceuticals.

More Related Videos

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
09:13

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

Related Experiment Videos

Last Updated: Jul 5, 2026

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
09:13

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Liver diseases and metastatic tumors are significant health concerns.
  • Targeted drug and gene delivery are crucial for effective DNA therapeutics.
  • Nanotechnology offers advanced solutions for site-specific delivery.

Purpose of the Study:

  • To review nano-vector systems for targeted liver gene delivery.
  • To explore receptor-mediated endocytosis for liver cell targeting.
  • To assess the potential of DNA therapeutics for liver disorders.

Main Methods:

  • Review of various nano-vectors: lipoplexes, liposomes, polyplexes, nanoparticles.
  • Investigation of receptor-mediated endocytosis pathways.
  • Focus on targeting liver parenchymal cells using receptors like ASGP-R.

Main Results:

  • Numerous nano-vectors have been developed for liver cell targeting.
  • Receptor-mediated endocytosis, particularly via ASGP-R, is effective for targeting liver cells.
  • Significant promise shown for developing novel DNA-based pharmaceuticals.

Conclusions:

  • Nanotechnology-based delivery systems offer a promising approach for liver gene therapy.
  • Targeted delivery to liver cells via receptor-mediated endocytosis is feasible.
  • Future development of DNA-based pharmaceuticals for liver disorders is highly anticipated.